- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 233/61 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
Patent holdings for IPC class C07D 233/61
Total number of patents in this class: 358
10-year publication summary
39
|
32
|
22
|
17
|
24
|
24
|
17
|
17
|
24
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Probiodrug AG | 76 |
7 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
7 |
Bristol-myers Squibb Company | 5080 |
6 |
BIAL - Portela & CA, S.A. | 243 |
6 |
PTC Therapeutics, Inc. | 492 |
6 |
Merck Patent GmbH | 5909 |
5 |
Centre National de La Recherche Scientifique | 9632 |
5 |
Agency for Science, Technology and Research | 3512 |
5 |
Institut Curie | 531 |
5 |
Toyama Chemical Co., Ltd. | 114 |
5 |
Seren Technologies Limited | 9 |
5 |
Bayer Pharma AG | 1096 |
4 |
President and Fellows of Harvard College | 5792 |
4 |
Takeda Pharmaceutical Company Limited | 2961 |
4 |
Dana-Farber Cancer Institute, Inc. | 2455 |
4 |
Dicerna Pharmaceuticals, Inc. | 278 |
4 |
EA Pharma Co., Ltd. | 77 |
4 |
Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
Universite de Montpellier | 920 |
4 |
Nissan Chemical Corporation | 1725 |
4 |
Other owners | 260 |